GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Panacos Pharmaceuticals PANC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Panacos Pharmaceuticals — daily PANC Delayed
Market value
$5,314
Last close × shares
Volume
200
Shares, 30 Oct 2026

About Panacos Pharmaceuticals

Its shares trade under the ticker PANC. It has been listed since 11 June 1998. In the fiscal year to 31 December 2007, it reported revenue of $180,000 and a net loss of $37.5m. At that date it held total assets of $55.7m and shareholders' equity of $28.9m.

Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. The company is headquartered in Watertown, Massachusetts. The firm's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The firm has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.

Figures and description from our data supplier, not checked against the company's own report.

More about Panacos Pharmaceuticals →

Latest on Panacos Pharmaceuticals

Our reporting

We have not reported on Panacos Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Panacos Pharmaceuticals's ticker?

Panacos Pharmaceuticals trades as PANC on its US listing, under ISIN US69811Q1067.

What was Panacos Pharmaceuticals's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.